Last edition
News about "Hoth Therapeutics "
Hoth Therapeutics Expands Phase IIa CLEER-001 Trial with New Miami Site
Hoth Therapeutics, Inc. has expanded its Phase IIa CLEER-001 trial with a new Miami site after promising interim results for HT-001 in managing skin toxicities linked to EGFR inhibitor cancer therapy.
Hoth Therapeutics | 26/02/2026 | By News Bureau
Hoth Therapeutics Announces Acquisition of New Patent Applications
Hoth Therapeutics continues to invest in robust research and development strategies, ensuring the protection and growth of its proprietary technologies.
Hoth Therapeutics | 22/01/2025 | By Aishwarya | 302
Hoth Therapeutics Signs Deal with Aronnax for HT-KIT Cancer Therapeutic
Hoth Therapeutics has signed a Master Services Agreement with Aronnax, Inc. for its HT-KIT cancer therapeutic.
Hoth Therapeutics | 16/08/2024 | By Aishwarya | 482
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy